|
Re: The synergy of rosuvastatin (Crestor) with apabetalone
|
1
|
Resverlogix Corp.
|
Oct 07, 2019 10:21AM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
1
|
Resverlogix Corp.
|
Jun 14, 2020 12:54PM
|
|
Re: Can Hepalink afford US rights?
|
1
|
Resverlogix Corp.
|
Feb 04, 2019 03:51PM
|
|
Re: Exercise of options Norma Biln
|
1
|
Resverlogix Corp.
|
Jul 29, 2020 02:42PM
|
|
Re: CNBC at the JPM Bio Tech Conference
|
1
|
Resverlogix Corp.
|
Jan 07, 2019 10:10AM
|
|
Another Promissory Note -Exempt Distribution
|
1
|
Zenith Epigenetics
|
Jul 17, 2024 07:21AM
|
|
BNN Bloomberg
|
1
|
Resverlogix Corp.
|
Apr 23, 2019 01:00PM
|
|
Re: COLCORONA trial: Colchicine reduces the risk of COVID-19-related complications
|
1
|
Resverlogix Corp.
|
Jan 24, 2021 08:04AM
|
|
Re: Combined effects of BTI & RVX
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 06, 2021 11:42AM
|
|
Re: What's the deal with Zenith?
|
1
|
Zenith Epigenetics
|
Jun 22, 2023 05:00PM
|
|
Re: EDITRe: i would love to hear,..
|
1
|
Resverlogix Corp.
|
Dec 06, 2019 08:59AM
|
|
Re: IR response
|
1
|
Resverlogix Corp.
|
May 06, 2022 10:35AM
|
|
Re: Wow…
|
1
|
Zenith Epigenetics
|
Sep 24, 2024 01:35PM
|
|
Re: Are the ZHCLF shares on the OTCBB legit
|
1
|
Zenith Epigenetics
|
Aug 05, 2021 11:51AM
|
|
Re: got this & sent a response/follow up minutes before …
|
1
|
Zenith Epigenetics
|
Dec 12, 2023 02:35PM
|
|
Re: HL USA - Material or not?
|
1
|
Resverlogix Corp.
|
Apr 11, 2019 02:44PM
|
|
Re: Continued Roth coverage imo points to a Nasdaq listing....
|
1
|
Resverlogix Corp.
|
May 02, 2019 08:49AM
|
|
Exempt Distribution October 26, 2022
|
1
|
Zenith Epigenetics
|
Oct 30, 2022 06:40PM
|
|
Re: Rvxcf Short Numbers - down as low as they’ve been in long time
|
1
|
Resverlogix Corp.
|
Nov 01, 2023 04:32PM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
Jul 01, 2020 05:03PM
|
